OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic

MLA

OpenSAFELY Collaborative, et al. OpenSAFELY: Impact of National Guidance on Switching Anticoagulant Therapy during COVID-19 Pandemic. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....9e6281e34497a4afb2660be8b5b67df7&authtype=sso&custid=ns315887.

APA

OpenSAFELY Collaborative, Curtis, H. J., MacKenna, B., Walker, A. J., Croker, R., Mehrkar, A., Morton, C., Bacon, S., Hickman, G., Inglesby, P., Bates, C., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Rentsch, C. T., Williamson, E., … The OpenSAFELY Collaborative. (2021). OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic.

Chicago

OpenSAFELY Collaborative, Helen J Curtis, Brian MacKenna, Alex J Walker, Richard Croker, Amir Mehrkar, Caroline Morton, et al. 2021. “OpenSAFELY: Impact of National Guidance on Switching Anticoagulant Therapy during COVID-19 Pandemic,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....9e6281e34497a4afb2660be8b5b67df7&authtype=sso&custid=ns315887.